Latest filing published 28 Mar 2021 for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED, €3.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +21.3%Entry US$0.89 · Close at T+365 US$1.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jinhushen Biological Medical Science and Technology Co., Ltd: trading record in brief
Only one filing by Jinhushen Biological Medical Science and Technology Co., Ltd is known so far (28 March 2021): an open-market purchase, €3, in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. That is too little to draw conclusions. This summary is built from SGX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jinhushen Biological Medical Science and Technology Co., Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4 shares@ SGD 1.00100.0% of flowShareSGX-STISIN CNE100000924SGX:OD4UV4F6QH6YI3F3Canonical exit: 24 Jun 2021 (T+90)
1 of 1 declaration